Mast cell chymase promotes hypertrophic scar fibroblast proliferation and collagen synthesis by activating TGF‑β1/Smads signaling pathway

Chen,Hongming; Xu,Yanwen; Yang,Guanbin; Zhang,Qianqian; Huang,Xun; Yu,Liming; Dong,Xianglin

doi:10.3892/etm.2017.5082

Mast cell chymase promotes hypertrophic scar fibroblast proliferation and collagen synthesis by activating TGF‑β1/Smads signaling pathway

Authors:
- Hongming Chen
- Yanwen Xu
- Guanbin Yang
- Qianqian Zhang
- Xun Huang
- Liming Yu
- Xianglin Dong
View Affiliations

Affiliations: Department of Burns and Plastic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uyghur Autonomous Region 830011, P.R. China
Published online on: August 31, 2017 https://doi.org/10.3892/etm.2017.5082
Pages: 4438-4442

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study assessed the existence of mast cell chymase in hypertrophic scars and determined whether chymase promotes fibrosis via the transforming growth factor (TGF)‑β1/Smads signaling pathway. Five patients with hypertrophic scars and another five patients subjected to repair and reconstruction of other tissue defects were included in the present study. To detect the existence of mast cells and mast cell chymase in hypertrophic scars, immunohistochemistry was employed. To test the effect of chymase on TGF‑β1, angiotensin, and type I and III collagen mRNA expression in isolated hypertrophic scar fibroblasts in vitro, reverse‑transcription quantitative PCR was performed. To investigate how chymase affects TGF‑β1, phosphorylated (P)‑Smad2/3 as well as Smad4 and Smad7 protein expression, western blot analysis was used. Mast cell chymase was identified to promote the mRNA expression of TGF‑β1, angiotensin, and type I and III collagen in hypertrophic scar fibroblasts in a time‑ and dose‑dependent manner. Furthermore, treatment with 60 ng/ml mast cell chymase for 12 h led to the upregulation of TGF‑β1, P‑Smad2/3, Smad4 and Smad7 in hypertrophic scar fibroblasts. The present study demonstrated that mast cells and chymase are present in hypertrophic scars, and chymase promotes hypertrophic scar fibroblast proliferation and collagen synthesis by activating the TGF‑β1/Smads signaling pathway.

View Figures

View References

1	Beldon P: Abnormal scar formation in wound healing. Nurs Times. 96:44–45. 2000.PubMed/NCBI
2	Shi Y and Massagé J: Mechanisms of TGF-beta signaling from cell membrance to the nucleus. Cell. 113:685–700. 2003. View Article : Google Scholar : PubMed/NCBI
3	Douaiher J, Succar J, Lancerotto L, Gurish MF, Orgill DP, Hamilton MJ, Krilis SA and Stevens RL: Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing. Adv Immunol. 122:211–252. 2014. View Article : Google Scholar : PubMed/NCBI
4	Zhao XY, Zhao LY, Zheng QS, Su JL, Guan H, Shang FJ, Niu XL, He YP and Lu XL: Chymase induces profibrotic response via transforming growth factor-beta 1/Smad activation in rat cardiac fibroblasts. Mol Cell Biochem. 310:159–166. 2008. View Article : Google Scholar : PubMed/NCBI
5	Lindstedt KA, Wang Y, Shiota N, Saarinen J, Hyytiäinen M, Kokkonen JO, Keski-Oja J and Kovanen PT: Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: A novel function for chymase. FASEB J. 15:1377–1388. 2001. View Article : Google Scholar : PubMed/NCBI
6	Muto T and Fukami H: Recent chymase inhibitors and their effects in in vivo models. IDrugs. 5:1141–1150. 2002.PubMed/NCBI
7	Taipale J, Lohi J, Saarinen J, Kovanen PT and Keski-Oja J: Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem. 270:4689–4696. 1995. View Article : Google Scholar : PubMed/NCBI
8	Algermissen B, Hermes B, Feldmann-Boeddeker I, Bauer F and Henz BM: Mast cell chymase and tryptase during tissue turnover: Analysis on in vitro mitogenesis of fibroblasts and keratinocytes and alterations in cutaneous scars. Exp Dermatol. 8:193–198. 1999. View Article : Google Scholar : PubMed/NCBI
9	Fan SQ, Cai JL, Qin LY, Wang ZH, Liu ZZ and Sun ML: Effect of heparin on production of transforming growth factor (TGF)-beta1 and TGF-beta1 mRNA expression by human normal skin and hyperplastic scar fibroblasts. Ann Plast Surg. 60:299–305. 2008. View Article : Google Scholar : PubMed/NCBI
10	Cowin AJ, Holmes TM, Brosnan P and Ferguson MW: Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds. Eur J Dermatol. 11:424–431. 2001.PubMed/NCBI
11	Walraven M, Gouverneur M, Middelkoop E, Beelen RH and Ulrich MM: Altered TGF-β signaling in fetal fibroblasts: What is known about the underlying mechanisms? Wound Repair Regen. 22:3–13. 2014. View Article : Google Scholar : PubMed/NCBI
12	Blobe GC, Schiemann WP and Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med. 342:1350–1358. 2000. View Article : Google Scholar : PubMed/NCBI
13	Yamamoto T, Hartmann K, Eckes B and Krieg T: Role of stem cell factor and monocyte chemoattrctant protein in the interaction between fibroblasts and mast cells in fibrosis. J Dermatol Sci. 26:106–111. 2001. View Article : Google Scholar : PubMed/NCBI
14	Yu H, Bock O, Bayat A, Ferguson MW and Mrowietz U: Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring. J Plast Reconstr Aesthet Surg. 59:221–229. 2006. View Article : Google Scholar : PubMed/NCBI
15	Singer AJ and Clark RA: Cutaneous wound healing. N Engl J Med. 341:738–746. 1999. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Hermes B, Feldmann-Böddeker I, Welker P, Algermissen B, Steckelings MU, Grabbe J and Henz BM: Altered expression of mast cell chymase and tryptase and of c-Kit in human cutaneous scar tissue. J Invest Dermatol. 114:51–55. 2000. View Article : Google Scholar : PubMed/NCBI
18	Miller HR, Wright SH, Knight PA and Thornton EM: A novel function for transforming growth factor-beta1: Upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific beta-chymase, mouse mast cell protease-1. Blood. 93:3473–3486. 1999.PubMed/NCBI
19	Moyer KE, Saggers GC and Ehrlich HP: Mast cells promote fibroblast populated collagen lattice contraction through gap junction intercellular communication. Wound Repair Regen. 12:269–275. 2004. View Article : Google Scholar : PubMed/NCBI
20	Castagnoli C, Stella M, Berthod C, Magliacani G and Richiardi PM: TNF production and hypertrophic scarring. Cell Immunol. 147:51–63. 1993. View Article : Google Scholar : PubMed/NCBI
21	Sakaguchi H, Takai S, Sakaguchi M, Sugiyama T, Ishihara T, Yao Y, Miyazaki M and Ikeda T: Chymase and angiotensin converting enzyme activities in a hamster model of glaucoma filtering surgery. Curr Eye Res. 24:325–331. 2002. View Article : Google Scholar : PubMed/NCBI
22	Younan G, Suber F, Xing W, Shi T, Kunori Y, Abrink M, Pejler G, Schlenner SM, Rodewald HR, Moore FD Jr, et al: The inflammatory response following an epidermal burn depends on the activities of mouse mast cell proteases 4 and 5. J Immunol. 185:7681–7690. 2010. View Article : Google Scholar : PubMed/NCBI
23	Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC and Lan HY: Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdiffetrntiation in vitro. Kideny Int. 56:1455–1467. 1999. View Article : Google Scholar
24	Willis BC and Borok Z: TGF-beta-induced EMT: Mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol. 293:L525–L534. 2007. View Article : Google Scholar : PubMed/NCBI
25	Ghahary A, Shen YJ, Scott PG, Gong Y and Tredget EE: Enhanced expression of mRNA for transforming growth factor-beta, type I and type III procollagen in human postburn hypertrophic scar tissues. J Lab Clin Med. 122:465–473. 1993.PubMed/NCBI
26	Tredget EE, Wang R, Shen Q, Scott PG and Ghahary A: Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: Antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res. 20:143–151. 2000. View Article : Google Scholar : PubMed/NCBI
27	Verhaegen PD, van Zuijlen PP, Pennings NM, van Marle J, Niessen FB, van der Horst CM and Middelkoop E: Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis. Wound Repair Regen. 17:649–656. 2009. View Article : Google Scholar : PubMed/NCBI
28	Miyazono K, Maeda S and Imamura T: BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16:251–263. 2005. View Article : Google Scholar : PubMed/NCBI
29	Tao SJ and Sampath K: Alternative splicing of SMADs in differentiation and tissue homeostasis. Dev Growth Differ. 52:335–342. 2010. View Article : Google Scholar : PubMed/NCBI
30	Dabiri G, Campaner A, Morgan JR and Van De Water L: A TGF-beta1-dependent autocrine loop regulates the structure of focal adhesions in hypertrophic scar fibroblasts. J Invest Dermatol. 126:963–970. 2006. View Article : Google Scholar : PubMed/NCBI